Definitive Healthcare Corp (DH) PT Lowered to $7 at Deutsche Bank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Definitive Healthcare Corp (DH) PT Lowered to $9.50 at Stifel
May 8, 2024 8:12 AM EDTStifel analyst David Grossman lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $9.50 (from $11.00) while maintaining a Buy rating.... More
Definitive Healthcare Corp (DH) PT Lowered to $8 at Canaccord Genuity
May 8, 2024 6:57 AM EDTCanaccord Genuity analyst David Hynes Jr. lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $8.00 (from $10.00) while maintaining a Hold rating.... More
Definitive Healthcare Corp (DH) PT Lowered to $8 at Baird
May 8, 2024 6:40 AM EDTBaird analyst Joe Vruwink lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $8.00 (from $9.00) while maintaining a Neutral rating.... More
Morgan Stanley Downgrades Definitive Healthcare Corp (DH) to Equalweight
May 8, 2024 3:28 AM EDT(Updated - May 8, 2024 4:49 AM EDT)
Morgan Stanley analyst Craig Hettenbach downgraded Definitive Healthcare Corp (NASDAQ: DH) from Overweight to Equalweight with a price target of $9.00 (from $11.50).
The analyst comments "Downgrading to Equal-weight and lowering our PT to $9. We had stuck... More
Definitive Healthcare Corp. (DH) Reports In-Line Q1 EPS, provides guidance
May 7, 2024 5:37 PM EDTDefinitive Healthcare Corp. (NASDAQ: DH) reported Q1 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $63.5 million versus the consensus estimate of $64.02 million.
GUIDANCE:
Definitive Healthcare Corp. sees Q2 2024 EPS of $0.08-$0.09, versus the consensus... More
